Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Imac Holdings (BACK)
NASDAQ:BACK
Imac Holdings (BACK) Stock Price & Analysis
146 Followers
BACK Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.22 - $7.75
Previous Close$1.49
Volume122.52K
Average Volume (3M)239.60K
Market Cap
$1.71M
Enterprise Value$2.61M
Total Cash (Recent Filing)$224.65K
Total Debt (Recent Filing)$1.12M
Price to Earnings (P/E)―
Beta1.71
Next Earnings
Mar 28, 2024EPS Estimate
-$0.73Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-13.61
Shares Outstanding1,148,321
10 Day Avg. Volume101,979
30 Day Avg. Volume239,605
Standard Deviation0.31
R-Squared0.00150
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)-0.69
Price to Sales (P/S)0.18
Price to Cash Flow (P/CF)-0.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.31
Enterprise Value/Gross Profit0.18
Enterprise Value/Ebitda-0.20
Forecast
1Y Price Target
$8.25Price Target Upside453.69% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Imac Holdings News
PremiumCompany Announcements
Imac Holdings Expands Board with Renowned Oncology Experts
PremiumPress Releases
IMAC Holdings Announces Leadership Succession
PremiumCompany Announcements
Imac Holdings Cancels Merger, Acquires Theralink AssetsBulls Say, Bears Say
Bulls Say
Growth OpportunitiesWith the merger with Theralink completed, IMAC is poised for solid growth opportunities in the long term.
MergerIMAC is now a clinical research and commercialization company focused on innovative medical advancements and care in the oncology and neurological medical specialties.
Precision OncologyTheralink provides precision oncology data to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to both FDA-approved and investigational drug treatments.
Bears Say
Capital NeedsThe company has ~$0 million in cash and no debt, indicating an urgent need to raise capital soon.
Operational UncertaintyManagement declined to provide 2024 guidance, and there are no business operations until the merger with Theralink is completed.
Revenue PerformanceRevenue was $0 million, falling significantly short of the estimated $1.0 million.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BACK FAQ
What was Imac Holdings’s price range in the past 12 months?
Imac Holdings lowest stock price was $1.22 and its highest was $7.75 in the past 12 months.
What is Imac Holdings’s market cap?
Currently, no data Available
When is Imac Holdings’s upcoming earnings report date?
Imac Holdings’s upcoming earnings report date is Mar 28, 2024 which is 116 days ago.
How were Imac Holdings’s earnings last quarter?
Imac Holdings released its earnings results on Nov 16, 2023. The company reported -$2.63 earnings per share for the quarter, missing the consensus estimate of -$0.6 by -$2.03.
Is Imac Holdings overvalued?
According to Wall Street analysts Imac Holdings’s price is currently Undervalued.
Does Imac Holdings pay dividends?
Imac Holdings does not currently pay dividends.
What is Imac Holdings’s EPS estimate?
Imac Holdings’s EPS estimate is -$0.73.
How many shares outstanding does Imac Holdings have?
Imac Holdings has 1,148,321 shares outstanding.
What happened to Imac Holdings’s price movement after its last earnings report?
Imac Holdings reported an EPS of -$2.63 in its last earnings report, missing expectations of -$0.6. Following the earnings report the stock price went up 0.328%.
Which hedge fund is a major shareholder of Imac Holdings?
Among the largest hedge funds holding Imac Holdings’s share is Sheaff Brock Investment Advisors LLC. It holds Imac Holdings’s shares valued at N/A.
---
Imac Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.25 (453.69% Upside)
$8.25 (453.69% Upside)
Blogger Sentiment
Bullish
BACK Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 634.0 Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-55.57%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-84.41%
Trailing 12-Months
Company Description
Imac Holdings
IMAC Holdings, Inc. provides medical services through integrated medicine and chiropractic regeneration centers. Its services include medical treatments, regenerative medicine, physical medicine, physical therapy, spinal decompression and chiropractic manipulation. The company was founded by Matthew C. Wallis, Jason William Brame and Jeffrey S. Ervin in August 2000 and is headquartered in Brentwood, TN.
---
BACK Stock 12 Month Forecast
Average Price Target
$8.25
▲(453.69% Upside)
Technical Analysis
Best Analysts Covering BACK
1 Year
1 Year Success Rate
1/9 ratings generated profit
1 Year Average Return
-43.00%
reiterated a buy rating 2 months ago
Copying Edward Woo's trades and holding each position for 1 Year would result in 11.11% of your transactions generating a profit, with an average return of -43.00% per trade.
---